Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Meda

Deal Watch table for April 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Rumoured Valeant merger with Actavis stalls

Wall Street Journal claims talks have fallen through on $13bn merger

- PMLiVE

Mylan agrees $1.6bn deal to buy Agila injectables unit

Generics firm becomes “top three player” in injectables

Mylan to develop Lantus, Humalog and NovoLog generics

Signs Indian biotech deal to compete with the big-selling insulin brands

Mylan appoints two new board members

Melina Higgins is a former partner at Goldman Sachs and Rajiv Malik is president at Mylan

- PMLiVE

Merck blocks Mylan’s generic Zetia and Vytorin after appeal

Keeps patents of cholesterol medicines protected until April 2017

- PMLiVE

Biotech challenging big pharma for M&A deals

Purchasing power growth of 'big biotech' outpaces pharma sector

- PMLiVE

Swedish approval for Bayer’s long-term contraceptive Jaydess

Country is reference member state for approval under the decentralised EU procedure

- PMLiVE

Red Door Communications wins Meda oral health accounts

Agency tasked with raising profile of Difflam and new brand CB12

- PMLiVE

GE Healthcare, Mylan and Swedish Orphan Biovitrum launch new apps

Three new pharma mobile apps continue industry's focus on Apple products

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links